National Health Investors (NHI) Stock Overview
Incorporated in 1991, National Health Investors, Inc. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 2/6 |
| Dividends | 5/6 |
NHI Community Fair Values
Create NarrativeSee what 21 others think this stock is worth. Follow their fair value or set your own to get alerts.
National Health Investors, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$79.23 |
| 52 Week High | US$85.98 |
| 52 Week Low | US$65.13 |
| Beta | 0.79 |
| 1 Month Change | 4.07% |
| 3 Month Change | 11.95% |
| 1 Year Change | -4.93% |
| 3 Year Change | 30.48% |
| 5 Year Change | 35.23% |
| Change since IPO | 288.86% |
Recent News & Updates
Recent updates
National Health Investors: 5% Yield And Robust Growth In Plain Sight
Aug 10National Health Investors: Good Income Stock Poised For Senior Housing Boom
Mar 03National Health Investors: Back To 5% Yield Spells Buying Opportunity
Dec 12National Health Investors: From Struggles To Strength
Sep 29
Senior Housing Growth And Decisive Investments Set To Boost Investor Confidence
The company's consistent financial performance and strategic investments indicate a strong potential for revenue and FFO growth.National Health Investors: The Lack Of Upside Seems Obvious To Me Here
May 09National Health: Lots To Love, But Valuation Still On The High Side
Feb 23Catch The Senior Housing Rebound With National Health Investors
Nov 27National Health Investors: 7% Yielding REIT Has Improved On Most Metrics
Nov 13National Health Investors: Enjoy This Solid 7%+ Yield, For Now
Aug 30National Health: What We Got Wrong With This Healthcare REIT
Jun 14National Health Investors GAAP EPS of $0.04 misses by $0.65, revenue of $70.66M misses by $4.97M
Feb 216%-Yielding National Health Investors: No Pain, No Gain
Feb 06Shareholder Returns
| NHI | US Health Care REITs | US Market | |
|---|---|---|---|
| 7D | 0.2% | -0.5% | 0.7% |
| 1Y | -4.9% | 13.1% | 17.9% |
Return vs Industry: NHI underperformed the US Health Care REITs industry which returned 10% over the past year.
Return vs Market: NHI underperformed the US Market which returned 19.2% over the past year.
Price Volatility
| NHI volatility | |
|---|---|
| NHI Average Weekly Movement | 2.4% |
| Health Care REITs Industry Average Movement | 2.9% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 17.2% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NHI has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: NHI's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 30 | D. Mendelsohn | www.nhireit.com |
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
National Health Investors, Inc. Fundamentals Summary
| NHI fundamental statistics | |
|---|---|
| Market cap | US$3.72b |
| Earnings (TTM) | US$142.78m |
| Revenue (TTM) | US$350.60m |
Is NHI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NHI income statement (TTM) | |
|---|---|
| Revenue | US$350.60m |
| Cost of Revenue | US$10.06m |
| Gross Profit | US$340.54m |
| Other Expenses | US$197.76m |
| Earnings | US$142.78m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.01 |
| Gross Margin | 97.13% |
| Net Profit Margin | 40.72% |
| Debt/Equity Ratio | 74.7% |
How did NHI perform over the long term?
See historical performance and comparisonDividends
Does NHI pay a reliable dividends?
See NHI dividend history and benchmarks| National Health Investors dividend dates | |
|---|---|
| Ex Dividend Date | Sep 30 2025 |
| Dividend Pay Date | Oct 31 2025 |
| Days until Ex dividend | 10 days |
| Days until Dividend pay date | 41 days |
Does NHI pay a reliable dividends?
See NHI dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/09/18 11:56 |
| End of Day Share Price | 2025/09/18 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
National Health Investors, Inc. is covered by 24 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Juan Sanabria | BMO Capital Markets Equity Research |
| John Kim | BMO Capital Markets Equity Research |
| null null | BMO Capital Markets Equity Research |